An analyst at Piper Jaffray just upgraded Biogen (NASDAQ: BIIB) shares in a mid-day research note.

The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE